The relationship between alexithymia, anxiety, depression, and severity of the disease in psoriasis patients

Nazlı Dizen Namdar; İnci Arıkan

doi:10.28982/josam.693222

Authors

Nazlı Dizen Namdar https://orcid.org/0000-0002-9116-5489
İnci Arıkan https://orcid.org/0000-0001-5060-7722

DOI:

https://doi.org/10.28982/josam.693222

Keywords:

Anxiety, Depression, Alexithymia, Psoriasis, Quality of life

Abstract

Aim: It is known that psychological factors are significant in the onset and exacerbation periods of psoriasis. The purpose of this study is to evaluate the levels of anxiety, depression, and alexithymia in psoriasis patients and to determine their relationship with the severity of disease and quality of life.
Methods: In this case-control study, 71 patients with psoriasis and 86 healthy people constituted the study and control groups, respectively. The clinical severity of psoriasis was determined by the “Psoriasis Area Severity Index” (PASI). “Dermatological Life Quality Index” (DLQI) form was conducted on the patients, and the “Toronto Alexithymia Scale”, “Beck Depression Scale” and “Beck Anxiety Scale” questionnaires were used for both the patients and the controls.
Results: Anxiety and depression scores in psoriasis patients were significantly higher than controls (P=0.029, P=0.003, respectively), but there was no significant difference between alexithymia scores (P=0.158). A positive correlation was found between PASI and alexithymia scores (P=0.004), and between the DLQI score of psoriasis patients and anxiety, depression, alexithymia, and PASI scores (P<0.001, P=0.006, P=0.004, P=0.001, respectively).
Conclusion: In our study, anxiety and depression levels were high in psoriasis. As the levels of anxiety, depression, and alexithymia increased, the quality of life deteriorated. Psoriasis patients should be not evaluated dermatologically only, but also be assessed psychologically and directed to the psychiatry outpatient clinic when necessary.

Downloads

Download data is not yet available.

References

Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol. 2006;55:829-35.

Atakan N, Doğan S. Psoriazis Sistemik Bir Hastalık mıdır?. Turk J Dermatol. 2012;6:119-22.

Köşger F, Bilgili ME, Genek M, Yıldız B, Saraçoğlu N, Eşsizoğlu A. Psöriasis hastalarında depresyon, anksiyete ve yaşam kalitesinin hastalığın şiddeti ile ilişkisi. Journal of Mood Disorders (JMOOD). 2014;4(4):157-62.

İslamoğlu ZGK, Demirbaş GU, Unal M, Aydın M. Is there any association between childhood trauma and chronic dermatological diseases? A case control study. J Surg Med. 2019;3(4):292-6.

Gupta MA, Gupta AK, Haberman HF. Psoriasis and psychiatry: an update. Gen Hosp Psychiatry. 1987;9:157-66.

Russo PAJ, Ilchef R, Cooper AJ. Psychiatric morbidity of psoriasis:a rewiev. Australiasian Journal of Dermatology. 2004;45:155-61.

Schmitt JM, Ford DE. Role of depression in quality of life for patients with psoriasis. Dermatology. 2007;215(1):17-27.

Mercan S. Psikojenik Sonuçlar ve Komorbiditeler. Türkderm. 2010;44(1):25-35.

Sesliokuyucu C, Şahpolat M, Arı M. Psöriazisli Hastaların Depresyon, Anksiyete, Çocukluk Çağı Ruhsal Travması ve Yaşam Kalitesi ile Sosyodemografik Özelliklerinin Araştırılması. Journal of Mood Disorders (JMOOD). 2017;7(1):28-40.

Sifneos PE. Alexithymia and its relationship to hemispheric specialization, affect, and creativity. Psychiatr Clin North Am. 1988;11(3):287-92.

Doruk A, Tunca M, Koç E. Psöriyazis ve Alopesi Areatalı Erkek Olgularda Aleksitimi, Öfke-Öfke İfade Tarzı ve Mizaç-Karakter Özellikleri. Turkiye Klinikleri J Med Sci. 2009;29(6):1503-9.

Şaşıoğlu M, Gülol Ç, Tosun A. Aleksitimi Kavramı. Psikiyatride Güncel Yaklaşımlar-Current Approaches in Psychiatry. 2013;5(4):507-527.

Güz H, Ay M, Dilbaz N. Bir Grup Dermatolojik Hastalarda Aleksitimi, Depresyon ve Anksiyete. Düşünen Adam. 2000;13(3):161-5.

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-71.

Hisli N. Beck Depresyon Ölçeği’nin bir Türk örnekleminde geçerlilik ve güvenilirliği. Psikoloji Dergisi. 1988;6:118-22.

Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol. 1988;56:893-7.

Ulusoy M, Şahin NH, Erkmen H. Turkish version of the Beck Anxiety Inventory: Psychometric properties. J Cognitive Psychother. 1998;12:163-72.

Bagby RM, Parker JDA, Taylor GJ. The twenty item Toronto Alexithymia Scale I-II. Item selection and cross validation of the factor structure and Convergent, Discriminant, and Concurrent Validity. J Psychosom Res. 1994;38:23-40.

Güleç H, Yenel A. 20 Maddelik Toronto Aleksitimi Ölçeği Türkçe Uyarlamasının Kesme Noktalarına Göre Psikometrik Özellikleri. Klin Psikiyatr Derg. 2010;13:108-12.

Taycan O, Özdemir A, Erdoğan S. Alexithymia and Somatization in Depressed Patients: The Role of the Type of Somatic Symptom Attribution. Arch Neuropsychiatry. 2017;54:99-104.

Finlay AY, Khan GK. Dermatology life quality index (dlqi)–a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210-6.

Öztürkcan S, Ermertcan AT, Eser E, Şahin MT. Cross validation of the Turkish version of dermatology life quality index. Int J Dermatol. 2006;45:1300-7.

Yazici-Güleç M, Kılıç A, Gül Ü, Güleç H. Psoriasis Hastalarında Aleksitimi ve Öfke. Nöropsikiyatri Arşivi. 2009;46:169-74.

Devrimci-Özguven H, Kundakçı TN, Kumbasar H, Boyvat A. The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol. 2000;14(4):267-71.

Kilic A, Gulec MY, Gul U, Gulec H. Temperament and character profile of patients with psoriasis. J Eur Acad Dermatol Venereol. 2008;22(5):537-42.

Picardi A, Mazzotti E, Gaetano P, Cattaruzza MS, Baliva G, Melchi CF, et al. Stress, social support, emotional regulation, and exacerbation of diffuse plaque psoriasis. Psychosomatics. 2005;46:556-64.

Richards HL, Fortune DG, Griffiths CE, Main CJ. Alexithymia in patients with psoriasis: clinical correlates and psychometric properties of the Toronto Alexithymia Scale-20. J Psychosom Res. 2005;58(1):89-96.

Rapp SR, Feldman SR, Exum ML, Fleischer AB, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. 1999;4:401-7.

İnanır I, Aydemir Ö, Gündüz K, Danacı AE, Ermertcan AT. Psoriasisli hastalarda yaşam kalite ölçeği geliştirilmesi. TÜRKDERM. 2003;37:189-95.